A clinical prediction score for targeted creatinine testing before initiating tenofovir-based antiretroviral treatment in Cambodia

Journal of Acquired Immune Deficiency Syndromes

Volumn 65, Issue 4, 2014, Pages

  Van Griensven, Johan ^a,b   Phirum, Lay ^a   Thai, Sopheak ^a   Buyze, Jozefien ^b   Lynen, Lutgarde ^b  

^a Sihanouk Hospital Center of HOPE   (Cambodia)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HEMOGLOBIN; TENOFOVIR;

ADULT; ANTIVIRAL THERAPY; CAMBODIA; CLINICAL ASSESSMENT TOOL; CLINICAL PREDICTION TOOL; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CROSS-SECTIONAL STUDY; FEMALE; HEALTH CARE DELIVERY; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY DYSFUNCTION; LETTER; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM;

ADENINE; ADULT; ANTI-HIV AGENTS; CAMBODIA; CLINICAL MEDICINE; CREATININE; CROSS-SECTIONAL STUDIES; DECISION SUPPORT TECHNIQUES; FEMALE; HIV INFECTIONS; HUMANS; KIDNEY DISEASES; MALE; METABOLIC CLEARANCE RATE; ORGANOPHOSPHONATES;

EID: 84897996778     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000022     Document Type: Letter

References (10)

1. World Health Organization. Antiretroviral Therapy for HIV Infection in Adults and Adolescents, Recommendations for a Public Health Approach, 2010 Revision. Geneva, Switzerland: World Health Organization; 2010
2. Cooper RD, Wiebe N, Smith N, et al. Systematic review and meta-analysis: Renal safety of tenofovir disoproxil fumarate in HIV-infected patients. Clin Infect Dis. 2010;51:496-505
3. Miro JM, Cofan F, Trullas JC, et al. Renal dysfunction in the setting of HIV/AIDS. Curr HIV/AIDS Rep. 2012;9:187-199
4. World Health Organization. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection. Recommendations for a Public Health Approach. Geneva, Switzerland: World Health Organization; 2013
5. McGinn TG, Guyatt GH, Wyer PC, et al. Userś guides to the medical literature: XXII: How to use articles about clinical decision rules. Evidence-Based Medicine Working Group. JAMA. 2000;284:79-84
6. van Griensven J, Thai S. Predictors of immune recovery and the association with late mortality while on antiretroviral treatment in Cambodia. Trans R Soc Trop Med Hyg. 2011;105: 694-703
7. Thai S, Koole O, Un P, et al. Five-year experience with scaling-up access to antiretroviral treatment in an HIV care programme in Cambodia. Trop Med Int Health. 2009;14: 1048-1058
8. Phan V, Thai S, Choun K, et al. Incidence of treatment-limiting toxicity with stavudinebased antiretroviral therapy in Cambodia: A retrospective cohort study. PLoS One. 2012;7:e30647
9. Lynen L, An S, Koole O, et al. An algorithm to optimize viral load testing in HIV-positive patients with suspected first-line antiretroviral therapy failure in Cambodia. J Acquir Immune Defic Syndr. 2009;52:40-48
10. Seymour DG, Green M, Vaz FG. Making better decisions: Construction of clinical scoring systems by the Spiegelhalter-Knill-Jones approach. BMJ. 1990;300:223-226